|The Anya Sturdy|The Anya Sturdy|Charitable Trust for Medical|esearch||
|---|---|---|---|---|
|||Contents|||
|Reference and Administrative<br>Details|||||
|Trustees' Report||||2to4|
|Statement ofTrustees'|Responsibilities||||
|Independent<br>Examiner's<br>Report|||||
|Statement ofFinancial|Activities||||
|Balance Sheet|||||
|Notes to the Financial|Statements|||9to15|





## 

## 

## 

## 



## 

|The Anya Sturdy Charitable Trust for Medica||l|Research|||||||
|---|---|---|---|---|---|---|---|---|---|
|Trustees' Report||||||||||
|The trustees<br>present the annual<br>report together<br>with the financial<br>statements of|||he charity|for the year|||ended 5|||
|April 2023.||||||||||
|Objectives and activities||||||||||
|Objectsand aims||||||||||
|The objectives ofthe Charity are to:||||||||||
|-promote medical research and provide or facilitate the provision ofequipment|||nd care for|the relief of|||sickness|||
|or disabling<br>diseases and conditions for the benefit ofthe public; and||||||||||
|-make donations<br>towards or to otherwise<br>promote or assist such charitable<br>purp|||ses as the trustees|||may|see fit.|||
|This is performed<br>through<br>the awarding ofgrants,<br>in accordance with the terms|||fthe governing||document.|||The||
|trustees<br>consider<br>grant making<br>an effective method of delivering<br>these objec|||ives. Grants|are|awarded|||at|the|
|discretion ofthe trustees.||||||||||
|Public benefit||||||||||
|The trustees confirm that they have complied<br>with the requirements<br>ofsection||1|ofthe Charities||Act 2011|||to||
|have due regard to the public benefit guidance<br>published<br>by the Charity Commi|||sion for England|||and Wales.||||
|Achievements<br>and performance||||||||||
|During the year the Charity made donations to the following two organisations||otalling $112,230||||||||
|Barts Health NHS Trust|||||||44,149|||
|WIMM|||||||68,081|||
|The charity believes that the support it has given has assisted the bodies suppo|||d and they in turn|||have|been|||
|able to improve the circumstance ofthe beneficiaries oftheir work.||||||||||
|Applications<br>can be submitted<br>to the Trustees by charitable<br>institutions<br>and the|||applications|are|considered||||at|
|the Trustees meetings. Applications<br>should be in writing<br>and incorporate<br>full d|||ails ofthe charity|||for which||||
|funding<br>is requested. Acknowledgements<br>are not generally<br>sent out to unsucces|||ful applicants.|||||||
|Plans for future periods||||||||||
|Aims and key objectivesforfuture periods||||||||||
|The trustees<br>intend to continue providing<br>grants to meet the objectives ofthe ch|||ity but retaining||flexibility|||as to||
|the timing and scale ofgrant making.||||||||||
|Financial Review||||||||||
|The Trust's income from its investments<br>was f27,764(2022:f22,336).Other|i|come &om disposal of||||||||
|investments<br>was f75,804(2022:$,169,225) and the movement<br>in the value ofi||vestments<br>was ($208,794)||||||||
|(2022:(f31,091)).The investment<br>income facilitated charitable<br>expenditure<br>w||ich included||grants||awarded||of||
|f112,230(2022:f108,041),||||||||||





## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 





## 

## 

## 

## 







## 

## 





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|Donated services and facilities|||
|---|---|---|
|These are recognised<br>as income<br>when the charity has control over the item, an|conditions<br>associates with|the|
|donated<br>item have been met, the receipt ofeconomic benefit from the use by th|charity ofthe item is probable||
|and the economic benefit can be measured<br>reliably. In accordance with the Chariti|sSORP(FRS102),any general||
|volunteer time is not recognised.|||
|On receipt, the donated professional<br>services and donated facilities are recognise|on the basis ofthe value ofthe||
|gift to the charity<br>which<br>is the amount<br>the charity<br>would<br>have been willing to<br>facilities of equivalent<br>economic<br>benefit<br>on the open market;<br>a correspondin|pay to obtain these services <br>amount<br>is then recognised|or<br>in|
|expenditure<br>in the period ofreceipt,|||
|Resources expended|||
|Liabilities are recognised as resources expended<br>as soon as there is a legal orco|structive obligation<br>committing||
|the charity to the expenditure,<br>it is probable that settlement<br>will be required,<br>and|he amount ofthe obligation|can|
|be measured<br>reliably. All expenditure<br>is accounted for on an accruals basis. All|xpenses including<br>support costs||
|and governance<br>costs are allocated or apportioned<br>to the applicable<br>expenditure|eadings.||
|Irrecoverable<br>VAT is charged against the expenditure<br>heading<br>as and when it w|incurred.||
|Costs ofgenerating<br>funds|||
|Costs ofgenerating<br>funds comprise<br>those costs directly<br>attributable<br>to managi|g the investment<br>portfolio|and|
|raising investment<br>income.|||
|Charitable<br>activity|||
|Costs ofcharitable<br>activities include grants made and an apportionment<br>ofover|ead and support costs, including||
|governance<br>costs, where applicable.|||
|Grants payable<br>are payments<br>made to thirst parties<br>in the furtherance<br>ofthe c|aritable objectives ofthe Trust.||
|Single or multi-year<br>grants and the trustees have agreed to pay the grant withou|condition, orthe recipient has a||
|reasonable<br>expectation<br>that they will receive a grant and any condition<br>attachi<br>control ofthe Trust.|g to the grant is outside of|the|
|Governance<br>costs comprise costs relating to the general running ofthe charity as|pposed to those associated with||
|generating<br>funds or charitable<br>activity.|||
|Fixed asset investments|||
|Investments<br>are stated at closing mid-market<br>value at the balance sheet date.<br>and disposal are shown<br>in the Statement ofFinancial Activities.|y gains or losses on revaluation||
|Realised gains and losses|||
|All gains and losses are taken to the Statement ofFinancial Activities as they|ise. Realised gains and losses|on|
|investments<br>are calculated as the difference between the sale proceeds and ave|eunit purchase cost, Vnrealised||
|gains and losses are calculated<br>as the difference<br>between<br>the market value at|e year end and opening<br>market||
|value (or purchase<br>date iflater).|||
|Debtors|||
|Other debtors are recognised<br>at the settlement<br>amount.|||
|The notes on pages 9to 15 form an integral<br>part ofthese fin|ial statements.||
|Page IO|||





## 

## 

## 

## 

## 

## 


## 



## 

## 

|4|Charitable<br>expenditure|Charitable<br>expenditure||||||
|---|---|---|---|---|---|---|---|
||Analysis ofexpenditure|on charitable||activities||2023|2022|
||Grants awarded to institutions|||||112,230|108,041|
||Support and governance|costs (note||5)||(16,951)|(5,847)|
|||||||95,279|102,194|
||Grants by type ofcharity|||||2023|2022|
||Medical research grants|||||112,230|106,041|
||Other grants||||||2,000|
|||||||112,230|10$,041|
|5|Support and governance||costs|||||
|||||||2023|2022|
||Independent<br>examiner's|fees|(including||VAT)|1,770|1,270|
||Foreign exchange (gains) and losses|||||(18,821)|(7,192)|
||Other costs|||||100|75|
|||||||(16,951)|(59847)|





## 

## 





